With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
With the mission of "being a health promoter and serving the public", the company is committed to professional academic promotion, patient needs and health service.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Chongqing Jingdong Junzhuo Pharmaceutical Co., Ltd. attaches great importance to the international market. We pay attention to the international development and effects of new drugs, build a channel for product communication.
With the mission of “promoting professional promotion and serving public health”, the company is committed to professional academic promotion; meets the unmet therapeutic needs of patients, and focuses on serving patients' health.
Follow no set form, be enthusiastic and active, diligent and eager to learn, possessing both political integrity and ability. Talents are symbols of company value, shareholders are creators of value and one of the key elements of company competitiveness and the first factor to achieve the scientific development of the company.
經(jīng)國務院第22次常務會議審議原則通過 完善國家基本藥物制度是深化醫(yī)改、強化醫(yī)療衛(wèi)生基本公共服務的重要舉措?！丁敖】抵袊?030”規(guī)劃綱要》和《“十三五”衛(wèi)生與健康規(guī)劃》明確提出要鞏固完善基本藥物制度。2018年深化醫(yī)改工作將制定完善國家基本藥物制度的指導性文件列為重點任務予以安排。根據(jù)黨中央、國務院的決策部署和深化醫(yī)改工作安排，今年以來，國家衛(wèi)生健康委會同有關部門在深入調(diào)研、廣泛聽取各方意見的基礎上，起草了《關于完善國家基本藥物制度的意見》。按照國務院醫(yī)改領導小組會議精神，廣泛征求、充分吸收國家有關部門、省級衛(wèi)生健康部門、行業(yè)協(xié)會、研究機構(gòu)、醫(yī)療機構(gòu)等多方面的意見和建議，8月30日經(jīng)國務院第22次常務會議審議原則通過。
《關于完善國家基本藥物制度的意見》中具有普惠性的內(nèi)容
一是國家基本藥物覆蓋面更廣，品種數(shù)量不僅滿足常見病、慢性病、應急搶救等主要臨床需求，還聚焦癌癥、兒童、丙肝等病種，為不同疾病患者提供了多種用藥選擇。
二是更好滿足分級診療需求，各級醫(yī)療機構(gòu)統(tǒng)一執(zhí)行集中采購確定的品種、劑型、規(guī)格、廠家、價格，解決了上下級醫(yī)療機構(gòu)用藥不銜接問題，為患者在基層就近就醫(yī)提供更多便利，讓患者少跑路、少花錢。
三是基本藥物質(zhì)量更有保證，對通過仿制藥質(zhì)量和療效一致性評價的品種，明確要優(yōu)先納入基本藥物目錄，并鼓勵醫(yī)療機構(gòu)優(yōu)先采購和使用，同時通過實施基本藥物全品種覆蓋抽檢，加強生產(chǎn)環(huán)節(jié)監(jiān)督檢查等措施，為患者提供質(zhì)量安全信得過的藥品。
四是基本藥物供應更有保障，在有效解決“已短缺”藥品供應的基礎上，特別加強“易短缺”藥品風險監(jiān)測預警，把提早防范作為解決短缺苗頭問題的重要措施，為患者提供持續(xù)生產(chǎn)供應的基本藥物，讓患者不再為買不到藥而憂。
五是促進改革聯(lián)動更有效，集中帶量采購降藥價，合理用藥降藥費，在醫(yī)保和財政提供支撐保障的同時，鼓勵各地在高血壓、糖尿病、嚴重精神障礙等慢性疾病管理中，在保證藥效前提下優(yōu)先使用基本藥物，逐步提高基本藥物實際保障水平，讓患者愿意使用基本藥物。
?。ㄞD(zhuǎn)自國家衛(wèi)健委網(wǎng)站）
- Scan code pays attention to us -
National customer service：400 969 7233
Company address：F13, Building A, Shenzhou Zhihui Tiandi, 26 Honghu West Road, Yubei District, Chongqing Municipality
簡體中文
English